Exercise After Colon Cancer Treatment: A New Standard of Care?

A growing body of evidence suggests that structured physical exercise after completing chemotherapy for colon cancer can significantly reduce the risk of recurrence and improve overall survival. This isn’t just about feeling better; research indicates exercise can be as impactful as some drug treatments, but without the associated side effects. Here’s a glance at how incorporating physical activity into post-treatment care is changing the landscape of colon cancer survivorship.

The Groundbreaking CO21 CHALLENGE Trial

For years, healthcare professionals have suspected a link between physical activity and improved outcomes for cancer patients. However, establishing a definitive cause-and-effect relationship has been challenging. Recent research, particularly the CO21 CHALLENGE Trial, provides robust evidence supporting the benefits of exercise. Published in the New England Journal of Medicine and presented at the 2025 ASCO Annual Meeting, this international study demonstrates that exercise can prevent cancer from returning and prolong life.

Study Design and Participants

The CO21 CHALLENGE Trial involved 889 patients from Canada and Australia diagnosed with stage III or high-risk stage II colon cancer who had completed adjuvant chemotherapy. Participants were divided into two groups:

• Health Education Group: Received an information booklet on nutrition and exercise.
• Exercise Group: Received personalized support from a sports coach, with sessions every two weeks for the first year, then monthly for two years. The goal was to assist patients gradually integrate more physical activity into their daily routines.

Key Findings: Significant Improvements in Survival

After a median follow-up of 7.9 years, the results were compelling. The study found:

• Disease-free survival was significantly longer in the exercise group (hazard ratio for disease recurrence, new primary cancer, or death, 0.72; 95% confidence interval [CI], 0.55 to 0.94; P = 0.02).
• 5-year disease-free survival was 80.3% in the exercise group compared to 73.9% in the health-education group (difference, 6.4 percentage points; 95% CI, 0.6 to 12.2).
• Findings suggest longer overall survival in the exercise group (hazard ratio for death, 0.63; 95% CI, 0.43 to 0.94).
• 8-year overall survival was 90.3% in the exercise group and 83.2% in the health-education group (difference, 7.1 percentage points; 95% CI, 1.8 to 12.3).

Musculoskeletal adverse events were more common in the exercise group (18.5% vs. 11.5%), but no serious complications were reported.

How Does Exercise Combat Cancer?

Researchers are investigating the biological mechanisms behind these positive effects. Potential explanations include:

• Improved regulation of insulin, potentially slowing cancer cell growth.
• Enhanced immune system function, enabling better recognition and destruction of tumor cells.
• Reduction in chronic inflammation, often linked to cancer development.

A Shift in Cancer Care

Experts believe these findings warrant a shift in how post-cancer treatment is approached. “This is the first randomized phase 3 trial in patients with stage III and high-risk stage II colon cancer to demonstrate that post-treatment exercise is both achievable and effective in improving disease-free survival,” says Dr. Pamela Kunz of Yale School of Medicine, an ASCO expert in gastrointestinal cancers . The study suggests that exercise should be considered a core component of post-cancer care, alongside medical follow-ups, nutrition guidance, and psychological support.

Key Takeaways

• Structured exercise after colon cancer treatment can reduce the risk of recurrence and improve survival rates.
• The CO21 CHALLENGE Trial provides strong evidence supporting the benefits of exercise in colon cancer survivors.
• Exercise may work by improving insulin regulation, boosting the immune system, and reducing inflammation.
• Experts advocate for integrating exercise into standard post-cancer care protocols.